TN2011000187A1 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- TN2011000187A1 TN2011000187A1 TN2011000187A TN2011000187A TN2011000187A1 TN 2011000187 A1 TN2011000187 A1 TN 2011000187A1 TN 2011000187 A TN2011000187 A TN 2011000187A TN 2011000187 A TN2011000187 A TN 2011000187A TN 2011000187 A1 TN2011000187 A1 TN 2011000187A1
- Authority
- TN
- Tunisia
- Prior art keywords
- organic compounds
- alky
- polymorphs
- hydrates
- diol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/122—Propionic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/08—Salts thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08168862 | 2008-11-11 | ||
PCT/EP2009/064889 WO2010055027A2 (fr) | 2008-11-11 | 2009-11-10 | Composés organiques |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2011000187A1 true TN2011000187A1 (en) | 2012-12-17 |
Family
ID=42062355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TN2011000187A TN2011000187A1 (en) | 2008-11-11 | 2011-04-19 | Organic compounds |
Country Status (20)
Country | Link |
---|---|
US (2) | US8680146B2 (fr) |
EP (1) | EP2358660A2 (fr) |
JP (2) | JP2012508215A (fr) |
KR (1) | KR20110086142A (fr) |
CN (2) | CN105198760A (fr) |
AU (1) | AU2009315735B2 (fr) |
BR (1) | BRPI0921533A2 (fr) |
CA (1) | CA2741974A1 (fr) |
CL (1) | CL2011001041A1 (fr) |
CO (1) | CO6382154A2 (fr) |
EC (1) | ECSP11011121A (fr) |
IL (1) | IL212073A0 (fr) |
MA (1) | MA32877B1 (fr) |
MX (1) | MX2011004924A (fr) |
NZ (1) | NZ591999A (fr) |
PE (1) | PE20120012A1 (fr) |
RU (1) | RU2543621C2 (fr) |
TN (1) | TN2011000187A1 (fr) |
WO (1) | WO2010055027A2 (fr) |
ZA (1) | ZA201102272B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5042215B2 (ja) | 2005-05-26 | 2012-10-03 | ニューロン システムズ, インコーポレイテッド | 網膜疾患を処置するための組成物および方法 |
BRPI0921533A2 (pt) * | 2008-11-11 | 2016-01-12 | Novartis Ag | composto orgânicos |
EP2456752A2 (fr) | 2009-07-24 | 2012-05-30 | ratiopharm GmbH | Procédé pour la production de sels de fingolimod |
JP2014503478A (ja) | 2010-10-28 | 2014-02-13 | マピ ファーマ リミテッド | フィンゴリモドの調製のための中間の化合物およびプロセス |
WO2012071524A1 (fr) | 2010-11-24 | 2012-05-31 | Ratiopharm Gmbh | Sels d'arylsulfonates de fingolimod et leurs procédés de préparation |
EP2505589A1 (fr) | 2011-04-01 | 2012-10-03 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Nouveaux composés hétérocycliques de sphingolipides en tant que modulateurs de la signalisation de sphingolipides et leurs utilisations |
JO3177B1 (ar) | 2011-04-01 | 2018-03-08 | Novartis Ag | تركيبات تتالف من 2-أمينو-2- [ 2- ( 4- أكتيل فينيل ) إثيل ] بروبان - 3, 1- ديول |
CN102887829B (zh) * | 2012-09-05 | 2014-07-02 | 中国科学院上海药物研究所 | 芬戈莫德粘酸盐及其晶体的制备方法和用途 |
JP6484567B2 (ja) | 2013-03-05 | 2019-03-13 | バイオコン・リミテッドBiocon Limited | 2−アミノ−1,3−プロパンジオール化合物およびその塩の製造のための方法 |
WO2015053879A1 (fr) | 2013-10-11 | 2015-04-16 | Teikoku Pharma Usa, Inc. | Agoniste des récepteurs de la sphingosine-1-phosphate, dispositifs à ionophorèse et procédés d'utilisation associés |
KR101820330B1 (ko) | 2013-10-11 | 2018-01-19 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 국소 스핑고신-1-포스페이트 수용체 효현제 제형 및 이의 사용 방법 |
US9925138B2 (en) | 2015-01-20 | 2018-03-27 | Handa Pharmaceuticals, Llc | Stable solid fingolimod dosage forms |
AU2017264697A1 (en) | 2016-05-09 | 2018-11-22 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
CN109563057B (zh) | 2016-05-31 | 2022-06-24 | 大鹏药品工业株式会社 | 磺酰胺化合物或其盐 |
RU2627691C1 (ru) * | 2016-07-06 | 2017-08-10 | Олег Ростиславович Михайлов | Кристаллическая η-модификация 2-амино-2-(2-(4-октилфенил)этил)пропан-1,3-диол гидрохлорида, способ её получения и фармацевтическая композиция на её основе |
EP3694500A4 (fr) | 2017-10-10 | 2021-06-30 | Aldeyra Therapeutics, Inc. | Traitement de troubles inflammatoires |
WO2020006329A1 (fr) * | 2018-06-29 | 2020-01-02 | Forma Therapeutics, Inc. | Sels de (s)-(5-cyclobutoxy-2-méthyl-6-(1- (pipéridin-4-yl)-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)(cyclopropyl)méthanone et leurs formes solides |
JP2021533154A (ja) * | 2018-08-06 | 2021-12-02 | アルデイラ セラピューティクス, インコーポレイテッド | 多形化合物およびその使用 |
CA3156298A1 (fr) | 2019-10-31 | 2021-05-06 | Laetitia POUZOL | Combinaison d'un antagoniste de cxcr7 avec un modulateur du recepteur s1p1 |
EP4353709A1 (fr) * | 2021-05-31 | 2024-04-17 | Shanghai Yonsun Biotechnology Co., Ltd. | Sel pharmaceutique de fingolimod, son procédé de préparation, composition pharmaceutique le contenant et utilisation associée |
EP4212156A1 (fr) | 2022-01-13 | 2023-07-19 | Abivax | Combinaison de 8-chloro-n-(4-(trifluorométhoxy)phényl)quinolin-2-amine et de ses dérivés avec un modulateur de récepteur de s1p |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0155015B1 (ko) | 1992-10-21 | 1998-12-01 | 고우야 마사시 | 2-아미노-1,3-프로판디올 화합물 및 면역 억제제 |
ECSP951461A (es) | 1995-06-07 | 1998-04-07 | SINTESIS DE 3- {4-(2- AMINOETOXI) BENZOIL]-2-ARIL-6- HIDROXIBENZO {b] TIOFENOS (CASO X- 9295B) | |
ECSP972265A (es) | 1997-09-23 | 1998-11-30 | Dihidrato de d-olanzapina | |
FR2785607B1 (fr) | 1998-11-09 | 2001-02-09 | Rhodia Chimie Sa | Procede de preparation de tris(ether-amine) |
PT1457478T (pt) * | 1998-11-11 | 2017-10-26 | Mitsubishi Pharma Corp | Produção de 2-amino-2-[2-(4-alquil-fenil)etil]propano-1,3-dióis |
JP4627356B2 (ja) * | 1999-06-30 | 2011-02-09 | 松森 昭 | ウイルス性心筋炎の予防または治療薬剤 |
CN1524002A (zh) * | 2001-06-08 | 2004-08-25 | ��˹��ŵ�� | 治疗或预防产胰岛素细胞的移植排斥反应 |
KR20120125398A (ko) * | 2002-05-16 | 2012-11-14 | 노파르티스 아게 | 암에서 edg 수용체 결합제의 용도 |
GB0217152D0 (en) * | 2002-07-24 | 2002-09-04 | Novartis Ag | Organic compounds |
HUE028247T2 (en) | 2003-04-08 | 2016-12-28 | Novartis Ag | A solid oral composition comprising S1P receptor agonist and sugar alcohol |
JP5021488B2 (ja) * | 2004-12-21 | 2012-09-05 | メルク セローノ ソシエテ アノニム | スルホニルアミノ環式誘導体及びその使用 |
GT200600350A (es) | 2005-08-09 | 2007-03-28 | Formulaciones líquidas | |
US20080221200A1 (en) * | 2005-09-30 | 2008-09-11 | Malcolm Allison | Combination of Organic Compounds |
ES2414205T3 (es) * | 2006-06-02 | 2013-07-18 | The Ohio State University Research Foundation | Agentes terapéuticos para el tratamiento de linfoma de células del manto |
US7985586B2 (en) * | 2008-02-04 | 2011-07-26 | Georgia Health Sciences University | Oligodendrocyte precursor cell composition and methods of use |
BRPI0921533A2 (pt) * | 2008-11-11 | 2016-01-12 | Novartis Ag | composto orgânicos |
-
2009
- 2009-11-10 BR BRPI0921533A patent/BRPI0921533A2/pt not_active IP Right Cessation
- 2009-11-10 CA CA2741974A patent/CA2741974A1/fr not_active Abandoned
- 2009-11-10 US US13/128,832 patent/US8680146B2/en not_active Expired - Fee Related
- 2009-11-10 PE PE2011000987A patent/PE20120012A1/es not_active Application Discontinuation
- 2009-11-10 JP JP2011535129A patent/JP2012508215A/ja not_active Withdrawn
- 2009-11-10 EP EP09752168A patent/EP2358660A2/fr not_active Withdrawn
- 2009-11-10 WO PCT/EP2009/064889 patent/WO2010055027A2/fr active Application Filing
- 2009-11-10 CN CN201510547567.5A patent/CN105198760A/zh active Pending
- 2009-11-10 NZ NZ591999A patent/NZ591999A/xx not_active IP Right Cessation
- 2009-11-10 AU AU2009315735A patent/AU2009315735B2/en not_active Ceased
- 2009-11-10 MX MX2011004924A patent/MX2011004924A/es active IP Right Grant
- 2009-11-10 RU RU2011123365/04A patent/RU2543621C2/ru not_active IP Right Cessation
- 2009-11-10 CN CN2009801448205A patent/CN102256933A/zh active Pending
- 2009-11-10 KR KR1020117013304A patent/KR20110086142A/ko not_active Application Discontinuation
-
2011
- 2011-03-28 ZA ZA2011/02272A patent/ZA201102272B/en unknown
- 2011-03-31 IL IL212073A patent/IL212073A0/en unknown
- 2011-04-19 TN TN2011000187A patent/TN2011000187A1/fr unknown
- 2011-05-10 CL CL2011001041A patent/CL2011001041A1/es unknown
- 2011-05-12 CO CO11058592A patent/CO6382154A2/es not_active Application Discontinuation
- 2011-06-03 MA MA33910A patent/MA32877B1/fr unknown
- 2011-06-10 EC EC2011011121A patent/ECSP11011121A/es unknown
-
2014
- 2014-02-13 US US14/179,807 patent/US20140235722A1/en not_active Abandoned
-
2015
- 2015-04-24 JP JP2015089480A patent/JP2015178503A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ECSP11011121A (es) | 2011-07-29 |
US8680146B2 (en) | 2014-03-25 |
US20110218248A1 (en) | 2011-09-08 |
EP2358660A2 (fr) | 2011-08-24 |
BRPI0921533A2 (pt) | 2016-01-12 |
AU2009315735B2 (en) | 2013-01-10 |
RU2011123365A (ru) | 2012-12-20 |
CO6382154A2 (es) | 2012-02-15 |
MA32877B1 (fr) | 2011-12-01 |
KR20110086142A (ko) | 2011-07-27 |
PE20120012A1 (es) | 2012-02-02 |
JP2012508215A (ja) | 2012-04-05 |
MX2011004924A (es) | 2011-05-30 |
AU2009315735A1 (en) | 2010-05-20 |
ZA201102272B (en) | 2011-12-28 |
US20140235722A1 (en) | 2014-08-21 |
WO2010055027A3 (fr) | 2010-08-19 |
NZ591999A (en) | 2013-06-28 |
JP2015178503A (ja) | 2015-10-08 |
CA2741974A1 (fr) | 2010-05-20 |
WO2010055027A2 (fr) | 2010-05-20 |
CN105198760A (zh) | 2015-12-30 |
CL2011001041A1 (es) | 2011-10-07 |
RU2543621C2 (ru) | 2015-03-10 |
IL212073A0 (en) | 2011-06-30 |
CN102256933A (zh) | 2011-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2011000187A1 (en) | Organic compounds | |
MY153915A (en) | Organic compounds | |
IN2012DN03883A (fr) | ||
IN2012DN00624A (fr) | ||
MX2012007098A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
MX2012007161A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
UA105390C2 (ru) | МОТИВЫ ХИМИЧЕСКИХ МОДИФИКАЦИЙ ДЛЯ ИНГИБИТОРОВ И МИМЕТИКОВ мкРНК | |
AP2010005480A0 (en) | Small molecule inhibitors for the treatment or prevention of denque virus infection. | |
EP2297140A4 (fr) | Nouveaux composés de 1,2,4-oxadiazole et leurs procédés d'utilisation | |
MX2011007750A (es) | Composiciones y metodos para inhibicion de la ruta jak. | |
JO2892B1 (en) | CYP inhibitors 17 | |
WO2010055028A3 (fr) | Composés organiques | |
WO2007115821A3 (fr) | Composés organiques | |
MX368649B (es) | Mezclas fungicidas de penflufén. | |
MX2012004780A (es) | Inhibidores de akt. | |
HK1150555A1 (zh) | 用於治療動脈硬化的 -嘧啶二元胺的應用 | |
WO2011039735A3 (fr) | Composés ayant une activité inhibitrice et utilisations de ceux-ci | |
IL201921A0 (en) | 1,3-dihydroimidazol-2-thione derivative as inhibitors of dopamine-beta-hydroxylase | |
CO6382123A2 (es) | Antagonistas de la via hedgehog de ftalazina disustituida | |
MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. | |
MY150600A (en) | Use of opioid antagonists for treating urinary retention | |
HK1158073A1 (en) | Compound useful for treating cellulite | |
WO2010074936A3 (fr) | Enzastaurine dans le traitement du cancer | |
EP2499120A4 (fr) | Nouveaux composés de 1,3-oxazolidine et utilisation de ces derniers comme inhibiteurs de la rénine | |
CL2007000773A1 (es) | Uso de compuestos derivados de diazepina condensada para el tratamiento de un desorden cognitivo como add o adhd;o su uso para tratar spm o pmdd. |